Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-2-26
pubmed:abstractText
The study sought to investigate the relationship between efavirenz exposure and the CYP2B6 516G-->T(*6) genotype in HIV/AIDS outpatients, using pharmacokinetic modelling and simulation.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0031-6970
pubmed:author
pubmed:issnType
Print
pubmed:volume
64
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
357-65
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:18057928-Acquired Immunodeficiency Syndrome, pubmed-meshheading:18057928-Adult, pubmed-meshheading:18057928-Algorithms, pubmed-meshheading:18057928-Aryl Hydrocarbon Hydroxylases, pubmed-meshheading:18057928-Benzoxazines, pubmed-meshheading:18057928-Female, pubmed-meshheading:18057928-Gene Frequency, pubmed-meshheading:18057928-Genetic Variation, pubmed-meshheading:18057928-Genotype, pubmed-meshheading:18057928-HIV Infections, pubmed-meshheading:18057928-Humans, pubmed-meshheading:18057928-Male, pubmed-meshheading:18057928-Models, Statistical, pubmed-meshheading:18057928-Oxidoreductases, N-Demethylating, pubmed-meshheading:18057928-Population, pubmed-meshheading:18057928-Reverse Transcriptase Inhibitors, pubmed-meshheading:18057928-Sex Factors, pubmed-meshheading:18057928-Zimbabwe
pubmed:year
2008
pubmed:articleTitle
High prevalence of the CYP2B6 516G-->T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe.
pubmed:affiliation
Department of DMPK & BAC, African Institute of Biomedical Science and Technology (AiBST), P.O.Box 2294, Harare, Zimbabwe.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't